美国 · SEC FORM 4
PRECISION BIOSCIENCES INC
DTIL · Nasdaq · CIK 0001357874 · Healthcare · Biotechnology
内部人信号
3 位买方 · 3 条买入交易行 · $29.5K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ✓ 角色得分高 · 买入者中职位最高的是:Director
- ✓ Recent activity · latest purchase 2026-09-28
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 62.4
- 62.2
- 62.1
- 61.9
- 61.7
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -7.2%
- 3M
- -21.8%
- 6M
- +0.7%
- 12M
- +17.9%
波动率与流动性
- 波动率
- 75.0%
- Beta
- —
- 平均每日成交额
- USD 1.9M
估值
- 市值
- USD 185.5M
- P/E
- —
基本面
- 利润率
- -133.4%
- ROE
- -49.6%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-03 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 2,514,044
- 上期报告
- 2,223,477
- 日均成交量
- 285,278
- 回补天数
- 8.8
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Frankel Stanley | 买入 (P) | Common Stock | 1,000 | USD 6.00 | USD 6,000 | SEC 申报 ↗ |
| 2026-09-25 | Germano Geno J | 买入 (P) | Common Stock | 2,609 | USD 6.28 | USD 16,385 | SEC 申报 ↗ |
| 2026-09-25 | Brown Melinda | 买入 (P) | Common Stock | 1,135 | USD 6.27 | USD 7,116 | SEC 申报 ↗ |
| 2025-12-16 | Germano Geno J | 买入 (P) | Common Stock | 3,000 | USD 4.72 | USD 14,160 | SEC 申报 ↗ |
| 2025-12-16 | Frankel Stanley | 买入 (P) | Common Stock | 2,700 | USD 4.70 | USD 12,690 | SEC 申报 ↗ |
| 2025-12-15 | Brown Melinda | 买入 (P) | Common Stock | 1,381 | USD 4.97 | USD 6,864 | SEC 申报 ↗ |
| 2025-09-26 | Frankel Stanley | 买入 (P) | Common Stock | 2,700 | USD 4.97 | USD 13,419 | SEC 申报 ↗ |
| 2025-09-22 | Brown Melinda | 买入 (P) | Common Stock | 1,400 | USD 4.89 | USD 6,846 | SEC 申报 ↗ |
| 2025-06-25 | Buehler Kevin | 买入 (P) | Common Stock | 5,076 | USD 4.16 | USD 21,116 | SEC 申报 ↗ |
| 2025-06-25 | Brown Melinda | 买入 (P) | Common Stock | 1,682 | USD 4.14 | USD 6,963 | SEC 申报 ↗ |
| 2025-03-26 | Buehler Kevin | 买入 (P) | Common Stock | 4,523 | USD 4.67 | USD 21,122 | SEC 申报 ↗ |
| 2025-03-26 | Brown Melinda | 买入 (P) | Common Stock | 1,839 | USD 4.75 | USD 8,735 | SEC 申报 ↗ |
| 2025-03-25 | Germano Geno J | 买入 (P) | Common Stock | 3,250 | USD 5.30 | USD 17,225 | SEC 申报 ↗ |
| 2024-12-30 | Germano Geno J | 买入 (P) | Common Stock | 3,605 | USD 4.49 | USD 16,186 | SEC 申报 ↗ |
| 2024-12-27 | Kelly John Alexander | 买入 (P) | Common Stock | 2,113 | USD 4.75 | USD 10,037 | SEC 申报 ↗ |
Form 4 申报证据
41 transaction lines in the latest 365-day window; 256 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Frankel Stanley | 买入 (P) | Common Stock | 1,000 | USD 6.00 | USD 6,000 | SEC 申报 ↗ |
| 2026-09-25 | Germano Geno J | 买入 (P) | Common Stock | 2,609 | USD 6.28 | USD 16,385 | SEC 申报 ↗ |
| 2026-09-25 | Brown Melinda | 买入 (P) | Common Stock | 1,135 | USD 6.27 | USD 7,116 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Frankel Stanley | 买入 (P) | Common Stock | 1,000 | USD 6.00 | USD 6,000 | SEC 申报 ↗ |
| 2026-09-25 | Germano Geno J | 买入 (P) | Common Stock | 2,609 | USD 6.28 | USD 16,385 | SEC 申报 ↗ |
| 2026-09-25 | Brown Melinda | 买入 (P) | Common Stock | 1,135 | USD 6.27 | USD 7,116 | SEC 申报 ↗ |
| 2026-05-20 | Pire Shari Lisa | 期权行权/转换 (M) | Common Stock | 21,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Germano Geno J | 期权行权/转换 (M) | Common Stock | 21,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Frankel Stanley | 期权行权/转换 (M) | Common Stock | 21,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Buehler Kevin | 期权行权/转换 (M) | Common Stock | 21,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Brown Melinda | 期权行权/转换 (M) | Common Stock | 21,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-18 | Scimeca Dario | 卖出 (S) | Common Stock | 4,925 | USD 3.84 | USD 18,912 | SEC 申报 ↗ |
| 2026-02-18 | SMITH J. JEFFERSON | 卖出 (S) | Common Stock | 4,925 | USD 3.84 | USD 18,912 | SEC 申报 ↗ |
| 2026-02-18 | Kelly John Alexander | 卖出 (S) | Common Stock | 8,149 | USD 3.84 | USD 31,292 | SEC 申报 ↗ |
| 2026-02-18 | Amoroso Michael | 卖出 (S) | Common Stock | 20,559 | USD 3.84 | USD 78,947 | SEC 申报 ↗ |
| 2026-02-17 | Scimeca Dario | 期权行权/转换 (M) | Common Stock | 16,667 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | SMITH J. JEFFERSON | 期权行权/转换 (M) | Common Stock | 16,667 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Kelly John Alexander | 期权行权/转换 (M) | Common Stock | 27,584 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-17 | Amoroso Michael | 期权行权/转换 (M) | Common Stock | 67,797 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Amoroso Michael | 卖出 (S) | Common Stock | 34,799 | USD 4.17 | USD 145,112 | SEC 申报 ↗ |
| 2026-01-21 | Scimeca Dario | 卖出 (S) | Common Stock | 8,854 | USD 4.03 | USD 35,682 | SEC 申报 ↗ |
| 2026-01-21 | SMITH J. JEFFERSON | 卖出 (S) | Common Stock | 10,200 | USD 4.03 | USD 41,106 | SEC 申报 ↗ |
| 2026-01-21 | SMITH J. JEFFERSON | 期权行权/转换 (M) | Common Stock | 16,219 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-21 | Kelly John Alexander | 卖出 (S) | Common Stock | 15,213 | USD 4.03 | USD 61,308 | SEC 申报 ↗ |
| 2026-01-20 | Scimeca Dario | 期权行权/转换 (M) | Common Stock | 25,311 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-20 | SMITH J. JEFFERSON | 期权行权/转换 (M) | Common Stock | 12,947 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-20 | Kelly John Alexander | 期权行权/转换 (M) | Common Stock | 44,363 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-20 | Amoroso Michael | 期权行权/转换 (M) | Common Stock | 115,378 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-16 | Germano Geno J | 买入 (P) | Common Stock | 3,000 | USD 4.72 | USD 14,160 | SEC 申报 ↗ |
| 2025-12-16 | Frankel Stanley | 买入 (P) | Common Stock | 2,700 | USD 4.70 | USD 12,690 | SEC 申报 ↗ |
| 2025-12-15 | Brown Melinda | 买入 (P) | Common Stock | 1,381 | USD 4.97 | USD 6,864 | SEC 申报 ↗ |
| 2025-11-03 | Scimeca Dario | 卖出 (S) | Common Stock | 665 | USD 6.49 | USD 4,316 | SEC 申报 ↗ |
| 2025-11-03 | Kelly John Alexander | 卖出 (S) | Common Stock | 1,303 | USD 6.49 | USD 8,456 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | DTIL |
| CIK | 0001357874 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 256 transaction lines from 2020-01-06 to 2026-09-28 24 P purchase lines · 80 S sale lines · 152 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.